مقایسهٔ روشها
روشهای انتخابی خود را کنار هم مرور کنید؛ ردیفهای متفاوت برجسته شدهاند.
| پروفایل سلامت اندومتریوز-30× | پرسشنامه کیفیت زندگی مرتبط با یائسگی× | |
|---|---|---|
| حوزه | زنان و زایمان | زنان و زایمان |
| خانواده | Process / pipeline | Process / pipeline |
| سال پیدایش≠ | 2001 | 1996 |
| پدیدآور≠ | Jones, G. L., Kennedy, S. H., Barnard, A., Wong, J., & Jenkinson, C. | Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., Guyatt, G. H. |
| نوع | Self-report | Self-report |
| منبع بنیادین≠ | Jones, G. L., Kennedy, S. H., Barnard, A., Wong, J., & Jenkinson, C. (2001). Development of an endometriosis quality-of-life instrument: The Endometriosis Health Profile-30. Obstetrics & Gynecology, 98(2), 258-264. DOI ↗ | Hilditch, J. R., Lewis, J., Peter, A., van Maris, B., Ross, A., Franssen, E., Guyatt, G. H., Lethargy, S., & Improvement, T. (1996). A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas, 24(3), 161-175. DOI ↗ |
| نامهای دیگر | EHP-30, EHP-Core30 | MENQOL, Menopause Quality of Life |
| مرتبط | 3 | 3 |
| خلاصه≠ | The Endometriosis Health Profile-30 (EHP-30) is a disease-specific quality-of-life questionnaire comprising 30 core items measuring the multidimensional impact of endometriosis on women's health and well-being. Developed by Jones and colleagues in 2001, the EHP-30 assesses five core domains: pain, emotional well-being, social support, sexual relations, and work/study impacts. Optional modular items address specific endometriosis-related concerns (infertility, medical side effects, treatment). It is the gold-standard endometriosis-specific outcome measure used in clinical trials and endometriosis research. | The Menopause-Specific Quality of Life Questionnaire (MENQOL) is a 29-item self-report instrument designed to assess quality of life in women experiencing menopausal symptoms. Developed by Hilditch and colleagues in 1996, the MENQOL captures four interrelated symptom domains: vasomotor symptoms (hot flushes, night sweats), psychosocial symptoms (mood, stress, anxiety), physical symptoms (fatigue, aches, sleep), and sexual symptoms. It is the primary menopause-specific outcome measure used in hormone replacement therapy trials and menopause research. |
| ScholarGateمجموعهداده ↗ |
|
|